EdgeBio to Offer Clinical Exome Sequencing to Labs and Hospitals for in-House Interpretation | GenomeWeb

EdgeBio said last week that it has received CLIA certification for its next-generation sequencing operations and will offer a clinical exome sequencing test intended for large labs and hospitals that can do their own in-house interpretation of the results.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.